Hereditary predisposition in one third of Wilms' tumors (Hol et al., 2022) One third of children with a kidney tumor have hereditary predisposition for the disease, according to a new study.
Checkpoint inhibitors in the treatment of pediatric solid tumors (Geoerger et al., 2020) In this study researchers determined whether the drug atezolizumab, a so-called checkpoint inhibitor, was active and safe to use in children with solid tumors, including kidney tumors.